Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Independent Wellness vs Peak Wellness

Two GLP-1 desks, one scoreboard. We put Independent Wellness and Peak Wellness head-to-head on the published Brief Score — the same six factors, scored the same way.

No. 48 · Grade B−

Independent Wellness

Visit Independent Wellness Full brief →
vs
Higher Brief ScoreNo. 36 · Grade B

Peak Wellness

Visit Peak Wellness Full brief →

The verdict

Peak Wellness takes this head-to-head.

Peak Wellness scores 83 to 80 on our six-factor Brief Score — A polished, nationwide wellness brand at a premium price — but without a LegitScript badge to back the sticker.

That doesn't make Independent Wellness a bad call — it's best for readers who want mainstream telehealth glp-1 access. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
78
83
Supply Reliability
74
84
Transparency
88
82
Access Breadth
90
86
Clinical Oversight
74
80
Track Record
73
81
Independent WellnessBrief Score 80 · 83Peak Wellness

Price, coverage & the tracker

Independent WellnessPeak Wellness
Brief Score80/100 (B−)83/100 (B)
SemaglutideFrom $249/mo (all doses, compounded)$249/mo
TirzepatideFrom $379/mo (all doses, compounded)$349/mo
CoverageAll 50 statesAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
On the trackerNewnew to the tracker, no prior readingStableprice stable

Independent Wellness: New to the tracker on 1 August 2026. The published line reads From $249/mo (all doses, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

Peak Wellness: $249 sema / $349 tirz nationwide; no accreditation listed.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.